These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3735134)

  • 21. Disposition and toxicity of amphotericin-B in the hyperlipidemic Zucker rat model.
    Vadiei K; Lopez-Berestein G; Luke DR
    Int J Obes; 1990 Jun; 14(6):465-72. PubMed ID: 2401582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity as a risk factor in drug-induced organ injury. V. Toxicokinetics of gentamicin in the obese overfed rat.
    Salazar DE; Schentag JJ; Corcoran GB
    Drug Metab Dispos; 1992; 20(3):402-6. PubMed ID: 1355715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Free fatty acids and the binding of sulfonamides in the serum of genetically obese Zucker rat.
    Kaul S; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):317-20. PubMed ID: 3613761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiological pharmacokinetics and pharmacodynamics of (+/-)-verapamil in female rats.
    Todd EL; Abernethy DR
    Biopharm Drug Dispos; 1987; 8(3):285-97. PubMed ID: 3593905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion studies in the rabbit.
    Awni WM; Sawchuk RJ
    Drug Metab Dispos; 1985; 13(2):127-32. PubMed ID: 2859157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral lipid emulsion-induced atherosclerosis in the obese Zucker rat and its lean littermate.
    Saladino CF; Schneider M; Jonas EA; Grimes G
    Artery; 1992; 19(5):297-306. PubMed ID: 1444840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of nutritional status on the pharmacokinetics and pharmacodynamics of pentobarbital.
    Jung D; Prasad PP
    Drug Metab Dispos; 1989; 17(4):365-8. PubMed ID: 2571473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of D-fenfluramine in lean and obese rats.
    Fracasso C; Guiso G; Garattini S; Caccia S
    Appetite; 1988 Feb; 10(1):45-55. PubMed ID: 3355126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics, N1-glucuronidation, and N4-acetylation of sulfa-6-monomethoxine in humans.
    Vree TB; Beneken Kolmer EW; Hekster YA; Shimoda M; Ono M; Miura T
    Drug Metab Dispos; 1990; 18(6):852-8. PubMed ID: 1981528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of obesity on sulfonamide disposition in Zucker rats.
    Kaul S; Ritschel WA
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):273-83. PubMed ID: 3243323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic modeling of verapamil effects under steady-state and nonsteady-state conditions.
    Schwartz JB; Verotta D; Sheiner LB
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1032-8. PubMed ID: 2600802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of fat tissue volume on the distribution kinetics of biperiden as a function of age in rats.
    Yokogawa K; Nakashima E; Ichimura F
    Drug Metab Dispos; 1990; 18(2):258-63. PubMed ID: 1971583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic characteristics of the obese overfed rat.
    Corcoran GB; Salazar DE; Sorge CL
    Int J Obes; 1989; 13(1):69-79. PubMed ID: 2703295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma leptin turnover rates in lean and obese Zucker rats.
    Vilà R; Adán C; Rafecas I; Fernández-López JA; Remesar X; Alemany M
    Endocrinology; 1998 Nov; 139(11):4466-9. PubMed ID: 9794453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carnitine metabolism in lean and obese Zucker rats during starvation.
    Brady LJ; Brady PS; Albers L; Davis AT; Hoppel CL
    J Nutr; 1986 Apr; 116(4):668-74. PubMed ID: 3958811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metabolic clearance rate of corticosterone in lean and obese male Zucker rats.
    White BD; Corll CB; Porter JR
    Metabolism; 1989 Jun; 38(6):530-6. PubMed ID: 2725291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged accumulation of diazepam in obesity.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Clin Pharmacol; 1983; 23(8-9):369-76. PubMed ID: 6415130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity effects on nitrazepam disposition.
    Abernethy DR; Greenblatt DJ; Locniskar A; Ochs HR; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1986 Nov; 22(5):551-7. PubMed ID: 3790401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of obesity on the pharmacodynamics of nitroglycerin in conscious rats.
    Wang EQ; Fung HL
    AAPS PharmSci; 2002; 4(4):E28. PubMed ID: 12646000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
    McNamara PJ; Blouin RA
    J Pharm Sci; 1990 Apr; 79(4):301-4. PubMed ID: 2141075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.